The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cell and Gene Therapy CRO Market Research Report 2025

Global Cell and Gene Therapy CRO Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1949371

No of Pages : 86

Synopsis
A Cell and Gene Therapy Contract Research Organization (CRO) is a specialized service provider that offers support and expertise in conducting preclinical and clinical research for cell and gene therapy products. These CROs play a crucial role in advancing the development of cell and gene therapies by providing a wide range of services tailored to the unique requirements of these innovative treatments.
The global Cell and Gene Therapy CRO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Cell and Gene Therapy CRO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cell and Gene Therapy CRO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cell and Gene Therapy CRO in SMBs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cell and Gene Therapy CRO include Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy CRO.
The Cell and Gene Therapy CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell and Gene Therapy CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Labcorp
IQVIA Biotech
PPD
Medpace
Veristat
Parexel
Charles River Laboratories
Catalent Pharma Solutions
Premier Research
Catalent
Vial
Noble Life Sciences
Ergomed
Segment by Type
Preclinical CRO
Clinical CRO
Segment by Application
SMBs
Large Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy CRO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Preclinical CRO
1.2.3 Clinical CRO
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy CRO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy CRO Market Perspective (2019-2030)
2.2 Global Cell and Gene Therapy CRO Growth Trends by Region
2.2.1 Global Cell and Gene Therapy CRO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell and Gene Therapy CRO Historic Market Size by Region (2019-2024)
2.2.3 Cell and Gene Therapy CRO Forecasted Market Size by Region (2025-2030)
2.3 Cell and Gene Therapy CRO Market Dynamics
2.3.1 Cell and Gene Therapy CRO Industry Trends
2.3.2 Cell and Gene Therapy CRO Market Drivers
2.3.3 Cell and Gene Therapy CRO Market Challenges
2.3.4 Cell and Gene Therapy CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy CRO Players by Revenue
3.1.1 Global Top Cell and Gene Therapy CRO Players by Revenue (2019-2024)
3.1.2 Global Cell and Gene Therapy CRO Revenue Market Share by Players (2019-2024)
3.2 Global Cell and Gene Therapy CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy CRO Revenue
3.4 Global Cell and Gene Therapy CRO Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy CRO Revenue in 2023
3.5 Global Key Players of Cell and Gene Therapy CRO Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy CRO, Product and Application
3.7 Global Key Players of Cell and Gene Therapy CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy CRO Breakdown Data by Type
4.1 Global Cell and Gene Therapy CRO Historic Market Size by Type (2019-2024)
4.2 Global Cell and Gene Therapy CRO Forecasted Market Size by Type (2025-2030)
5 Cell and Gene Therapy CRO Breakdown Data by Application
5.1 Global Cell and Gene Therapy CRO Historic Market Size by Application (2019-2024)
5.2 Global Cell and Gene Therapy CRO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell and Gene Therapy CRO Market Size (2019-2030)
6.2 North America Cell and Gene Therapy CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell and Gene Therapy CRO Market Size by Country (2019-2024)
6.4 North America Cell and Gene Therapy CRO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy CRO Market Size (2019-2030)
7.2 Europe Cell and Gene Therapy CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell and Gene Therapy CRO Market Size by Country (2019-2024)
7.4 Europe Cell and Gene Therapy CRO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy CRO Market Size (2019-2030)
8.2 Asia-Pacific Cell and Gene Therapy CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell and Gene Therapy CRO Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell and Gene Therapy CRO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy CRO Market Size (2019-2030)
9.2 Latin America Cell and Gene Therapy CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell and Gene Therapy CRO Market Size by Country (2019-2024)
9.4 Latin America Cell and Gene Therapy CRO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy CRO Market Size (2019-2030)
10.2 Middle East & Africa Cell and Gene Therapy CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell and Gene Therapy CRO Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell and Gene Therapy CRO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Labcorp
11.1.1 Labcorp Company Details
11.1.2 Labcorp Business Overview
11.1.3 Labcorp Cell and Gene Therapy CRO Introduction
11.1.4 Labcorp Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.1.5 Labcorp Recent Development
11.2 IQVIA Biotech
11.2.1 IQVIA Biotech Company Details
11.2.2 IQVIA Biotech Business Overview
11.2.3 IQVIA Biotech Cell and Gene Therapy CRO Introduction
11.2.4 IQVIA Biotech Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.2.5 IQVIA Biotech Recent Development
11.3 PPD
11.3.1 PPD Company Details
11.3.2 PPD Business Overview
11.3.3 PPD Cell and Gene Therapy CRO Introduction
11.3.4 PPD Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.3.5 PPD Recent Development
11.4 Medpace
11.4.1 Medpace Company Details
11.4.2 Medpace Business Overview
11.4.3 Medpace Cell and Gene Therapy CRO Introduction
11.4.4 Medpace Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.4.5 Medpace Recent Development
11.5 Veristat
11.5.1 Veristat Company Details
11.5.2 Veristat Business Overview
11.5.3 Veristat Cell and Gene Therapy CRO Introduction
11.5.4 Veristat Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.5.5 Veristat Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel Cell and Gene Therapy CRO Introduction
11.6.4 Parexel Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.6.5 Parexel Recent Development
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Company Details
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories Cell and Gene Therapy CRO Introduction
11.7.4 Charles River Laboratories Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.7.5 Charles River Laboratories Recent Development
11.8 Catalent Pharma Solutions
11.8.1 Catalent Pharma Solutions Company Details
11.8.2 Catalent Pharma Solutions Business Overview
11.8.3 Catalent Pharma Solutions Cell and Gene Therapy CRO Introduction
11.8.4 Catalent Pharma Solutions Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.8.5 Catalent Pharma Solutions Recent Development
11.9 Premier Research
11.9.1 Premier Research Company Details
11.9.2 Premier Research Business Overview
11.9.3 Premier Research Cell and Gene Therapy CRO Introduction
11.9.4 Premier Research Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.9.5 Premier Research Recent Development
11.10 Catalent
11.10.1 Catalent Company Details
11.10.2 Catalent Business Overview
11.10.3 Catalent Cell and Gene Therapy CRO Introduction
11.10.4 Catalent Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.10.5 Catalent Recent Development
11.11 Vial
11.11.1 Vial Company Details
11.11.2 Vial Business Overview
11.11.3 Vial Cell and Gene Therapy CRO Introduction
11.11.4 Vial Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.11.5 Vial Recent Development
11.12 Noble Life Sciences
11.12.1 Noble Life Sciences Company Details
11.12.2 Noble Life Sciences Business Overview
11.12.3 Noble Life Sciences Cell and Gene Therapy CRO Introduction
11.12.4 Noble Life Sciences Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.12.5 Noble Life Sciences Recent Development
11.13 Ergomed
11.13.1 Ergomed Company Details
11.13.2 Ergomed Business Overview
11.13.3 Ergomed Cell and Gene Therapy CRO Introduction
11.13.4 Ergomed Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.13.5 Ergomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Cell and Gene Therapy CRO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Preclinical CRO
Table 3. Key Players of Clinical CRO
Table 4. Global Cell and Gene Therapy CRO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Cell and Gene Therapy CRO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cell and Gene Therapy CRO Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Cell and Gene Therapy CRO Market Share by Region (2019-2024)
Table 8. Global Cell and Gene Therapy CRO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Cell and Gene Therapy CRO Market Share by Region (2025-2030)
Table 10. Cell and Gene Therapy CRO Market Trends
Table 11. Cell and Gene Therapy CRO Market Drivers
Table 12. Cell and Gene Therapy CRO Market Challenges
Table 13. Cell and Gene Therapy CRO Market Restraints
Table 14. Global Cell and Gene Therapy CRO Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Cell and Gene Therapy CRO Market Share by Players (2019-2024)
Table 16. Global Top Cell and Gene Therapy CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CRO as of 2023)
Table 17. Ranking of Global Top Cell and Gene Therapy CRO Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Cell and Gene Therapy CRO Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Cell and Gene Therapy CRO, Headquarters and Area Served
Table 20. Global Key Players of Cell and Gene Therapy CRO, Product and Application
Table 21. Global Key Players of Cell and Gene Therapy CRO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell and Gene Therapy CRO Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Cell and Gene Therapy CRO Revenue Market Share by Type (2019-2024)
Table 25. Global Cell and Gene Therapy CRO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Cell and Gene Therapy CRO Revenue Market Share by Type (2025-2030)
Table 27. Global Cell and Gene Therapy CRO Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Cell and Gene Therapy CRO Revenue Market Share by Application (2019-2024)
Table 29. Global Cell and Gene Therapy CRO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Cell and Gene Therapy CRO Revenue Market Share by Application (2025-2030)
Table 31. North America Cell and Gene Therapy CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Cell and Gene Therapy CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Cell and Gene Therapy CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Cell and Gene Therapy CRO Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Cell and Gene Therapy CRO Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cell and Gene Therapy CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Cell and Gene Therapy CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
Table 46. Labcorp Company Details
Table 47. Labcorp Business Overview
Table 48. Labcorp Cell and Gene Therapy CRO Product
Table 49. Labcorp Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 50. Labcorp Recent Development
Table 51. IQVIA Biotech Company Details
Table 52. IQVIA Biotech Business Overview
Table 53. IQVIA Biotech Cell and Gene Therapy CRO Product
Table 54. IQVIA Biotech Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 55. IQVIA Biotech Recent Development
Table 56. PPD Company Details
Table 57. PPD Business Overview
Table 58. PPD Cell and Gene Therapy CRO Product
Table 59. PPD Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 60. PPD Recent Development
Table 61. Medpace Company Details
Table 62. Medpace Business Overview
Table 63. Medpace Cell and Gene Therapy CRO Product
Table 64. Medpace Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 65. Medpace Recent Development
Table 66. Veristat Company Details
Table 67. Veristat Business Overview
Table 68. Veristat Cell and Gene Therapy CRO Product
Table 69. Veristat Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 70. Veristat Recent Development
Table 71. Parexel Company Details
Table 72. Parexel Business Overview
Table 73. Parexel Cell and Gene Therapy CRO Product
Table 74. Parexel Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 75. Parexel Recent Development
Table 76. Charles River Laboratories Company Details
Table 77. Charles River Laboratories Business Overview
Table 78. Charles River Laboratories Cell and Gene Therapy CRO Product
Table 79. Charles River Laboratories Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 80. Charles River Laboratories Recent Development
Table 81. Catalent Pharma Solutions Company Details
Table 82. Catalent Pharma Solutions Business Overview
Table 83. Catalent Pharma Solutions Cell and Gene Therapy CRO Product
Table 84. Catalent Pharma Solutions Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 85. Catalent Pharma Solutions Recent Development
Table 86. Premier Research Company Details
Table 87. Premier Research Business Overview
Table 88. Premier Research Cell and Gene Therapy CRO Product
Table 89. Premier Research Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 90. Premier Research Recent Development
Table 91. Catalent Company Details
Table 92. Catalent Business Overview
Table 93. Catalent Cell and Gene Therapy CRO Product
Table 94. Catalent Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 95. Catalent Recent Development
Table 96. Vial Company Details
Table 97. Vial Business Overview
Table 98. Vial Cell and Gene Therapy CRO Product
Table 99. Vial Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 100. Vial Recent Development
Table 101. Noble Life Sciences Company Details
Table 102. Noble Life Sciences Business Overview
Table 103. Noble Life Sciences Cell and Gene Therapy CRO Product
Table 104. Noble Life Sciences Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 105. Noble Life Sciences Recent Development
Table 106. Ergomed Company Details
Table 107. Ergomed Business Overview
Table 108. Ergomed Cell and Gene Therapy CRO Product
Table 109. Ergomed Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
Table 110. Ergomed Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report


List of Figures
Figure 1. Cell and Gene Therapy CRO Picture
Figure 2. Global Cell and Gene Therapy CRO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Cell and Gene Therapy CRO Market Share by Type: 2023 VS 2030
Figure 4. Preclinical CRO Features
Figure 5. Clinical CRO Features
Figure 6. Global Cell and Gene Therapy CRO Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Cell and Gene Therapy CRO Market Share by Application: 2023 VS 2030
Figure 8. SMBs Case Studies
Figure 9. Large Companies Case Studies
Figure 10. Cell and Gene Therapy CRO Report Years Considered
Figure 11. Global Cell and Gene Therapy CRO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Cell and Gene Therapy CRO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Cell and Gene Therapy CRO Market Share by Region: 2023 VS 2030
Figure 14. Global Cell and Gene Therapy CRO Market Share by Players in 2023
Figure 15. Global Top Cell and Gene Therapy CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CRO as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Cell and Gene Therapy CRO Revenue in 2023
Figure 17. North America Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Cell and Gene Therapy CRO Market Share by Country (2019-2030)
Figure 19. United States Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Cell and Gene Therapy CRO Market Share by Country (2019-2030)
Figure 23. Germany Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Cell and Gene Therapy CRO Market Share by Region (2019-2030)
Figure 31. China Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Cell and Gene Therapy CRO Market Share by Country (2019-2030)
Figure 39. Mexico Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Cell and Gene Therapy CRO Market Share by Country (2019-2030)
Figure 43. Turkey Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. UAE Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Labcorp Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 47. IQVIA Biotech Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 48. PPD Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 49. Medpace Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 50. Veristat Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 51. Parexel Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 52. Charles River Laboratories Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 53. Catalent Pharma Solutions Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 54. Premier Research Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 55. Catalent Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 56. Vial Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 57. Noble Life Sciences Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 58. Ergomed Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’